1. Home
  2. ADPT vs PTON Comparison

ADPT vs PTON Comparison

Compare ADPT & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$12.44

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Peloton Interactive Inc.

PTON

Peloton Interactive Inc.

N/A

Current Price

$3.77

Market Cap

2.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
ADPT
PTON
Founded
2009
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
ADPT
PTON
Price
$12.44
$3.77
Analyst Decision
Strong Buy
Buy
Analyst Count
9
13
Target Price
$17.78
$8.05
AVG Volume (30 Days)
1.5M
9.8M
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
63.89
80.13
EPS
N/A
N/A
Revenue
$276,976,000.00
N/A
Revenue This Year
$3.98
N/A
Revenue Next Year
$22.72
$0.60
P/E Ratio
N/A
N/A
Revenue Growth
54.77
N/A
52 Week Low
$6.68
$3.68
52 Week High
$20.76
$9.20

Technical Indicators

Market Signals
Indicator
ADPT
PTON
Relative Strength Index (RSI) 24.22 30.95
Support Level $12.32 N/A
Resistance Level $13.45 $4.53
Average True Range (ATR) 0.83 0.18
MACD -0.26 0.05
Stochastic Oscillator 10.61 17.52

Price Performance

Historical Comparison
ADPT
PTON

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: